Wasting syndrome in HIV/AIDS patients. A guide to prevention and management.
Woolard
S
S
D019380:Anti-HIV Agents / Q000627:therapeutic use; D019167:Appetite Stimulants / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D019247:HIV Wasting Syndrome / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007333:Insulin Resistance; D018977:Micronutrients / Q000627:therapeutic use; D009722:Nurse Practitioners; D011320:Primary Health Care / Q000379:methods*; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors; D013739:Testosterone / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use; D015431:Weight Loss
D019380:Anti-HIV Agents; D019167:Appetite Stimulants; D018977:Micronutrients; D019382:Human Growth Hormone; D013739:Testosterone; D013792:Thalidomide